Oxidative stress in COPD patients, smokers, and non-smokers

Respiratory Care

Volumn 57, Issue 12, 2012, Pages 2090-2094

  Tavilani, Heidar ^a   Nadi, Ebrahim ^b   Karimi, Jamshid ^a   Goodarzi, Mohammad Taghi ^c  

^a Medical School   (Iran)

^b Shahid Beheshti Hospital   (Iran)

^c HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antioxidants; COPD; Smoking

Indexed keywords

CATALASE; CERULOPLASMIN; FERRITIN; GLUTATHIONE REDUCTASE; SUPEROXIDE DISMUTASE;

AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FUNCTIONAL STATUS; HEALTH STATUS; HUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; SMOKING HABIT; SPIROMETRY;

AGED; CERULOPLASMIN; FEMALE; FERRITINS; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; SPIROMETRY;

EID: 84870798119     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.01809     Document Type: Article

References (26)

1. Rahman I, Swarska E, Henry M, Stolk J, MacNee W. Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease? Thorax 2000;55(3):189-193.
2. Frank L. Developmental aspects of experimental pulmonary oxygen toxicity. Free Radic Biol Med 1991;11(5):463-494.
3. Domej W, Foldes-Papp Z, Flogel E, Haditsch B. Chronic obstructive pulmonary disease and oxidative stress. Current pharmaceutical biotechnology 2006;7(2):117-123.
4. Fletcher CM, Pride NB. Definitions of emphysema, chronic bronchitis, asthma, and airflow obstruction: 25 years on from the Ciba symposium. Thorax 1984;39(2):81-85.
5. Kinnula VL. Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases. Thorax 2005;60(8):693-700.
6. Snider GL. Chronic obstructive pulmonary disease: a definition and implications of structural determinants of airflow obstruction for epidemiology. Am Rev Respir Dis 1989;140(3 Pt 2):S3-S8.
7. Pryor WA, Stone K. Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann N Y Acad Sci 1993;686:12-27, discussion 27-28.
8. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometery. Eur Respir J 2005;26(2):319-38.
9. Snider GL, Woolf CR, Kory RC, et al. Criteria for the assessment of reversibility in airway obstruction: report of the committee on Emphysema, American College of Chest Physicians Chest 1974;65(5): 552-553.
10. Celli BR, MacNee W; American Thoracic Society/European Respiratory Society Task Force. Standards for the diagnosis and management of patients with diagnosis of patients with COPD: a summary position paper. Eur Respir J 2004;23(6):932-946. Erratum in: Eur Respir J 2006;27(1):242.
11. World Health Organization. European health for all databases. Updated January 2012. http://www.euro.who.int/en/what-we-do/dataand-evidence/databases/european-health-for-all-database-hfa-db2. Accessed September 21, 2012.
12. Karincaoglu Y, Batcioglu K, Erdem T, Esrefoglu M, Genc M. The levels of plasma and salivary antioxidants in the patient with recurrent aphthous stomatitis. J Oral Pathol Med. 2005;34:7-12.
13. Schosinsky KH, Lehmann PH, Beeler MF. Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride. Clin Chem, 1974;20(12):1558-1563.
14. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004;59(7):574-580.
15. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003; 22(4):672-688.
16. van der Vaart H, Postma DS, Timens W, ten Hacken NH. Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax 2004;59(8):713-721.
17. Carter AB, Tephly LA, Venkataraman S, Oberley LW, Zhang Y, Buettner GR, et al. High levels of catalase and glutathione peroxidase activity dampen H2O2 signaling in human alveolar macrophages. Am J Respir Cell Mol Biol 2004;31(1):43-53.
18. Mak JC, Ho SP, Yu WC, Choo KL, Chu CM, Yew WW, et al. Polymorphisms and functional activity in superoxide dismutase and catalase genes in smokers with COPD. Eur Respir J 2007;30(4):684-690.
19. Gilks CB, Price K, Wright JL, Churg A. Antioxidant gene expression in rat lung after exposure to cigarette smoke. Am J Pathol 1998; 152(1):269-278.
20. Lakari E, Paakko P, Kinnula VL. Manganese superoxide dismutase, but not CuZn superoxide dismutase, is highly expressed in the granulomas of pulmonary sarcoidosis and extrinsic allergic alveolitis. Am J Respir Crit Care Med 1998;158(2):589-596.
21. Montaño M, Cisneros J, Ramírez-Venegas A, Pedraza-Chaverri J, Mercado D, Ramos C, Sansores RH. Malondialdehyde and superoxide dismutase correlate with FEV1 in patients with COPD associated with wood smoke exposure and tobacco smoking. Inhal Toxicol 2010;22(10):868-874.
22. Rahman I, Biswas SK, Jimenez LA, Torres M, Forman HJ. Glutathione, stress responses, and redox signaling in lung inflammation. Antioxid Redox Signal 2005;7(1-2):42-59.
23. Thompson AB, Bohling T, Heires A, Linder J, Rennard SI. Lower respiratory tract iron burden is increased in association with cigarette smoking. J Lab Clin Med 1991;117(6):493-499.
24. Galdston M, Feldman JG, Levytska V, Magnusson B. Antioxidant activity of serum ceruloplasmin and transferrin available iron-binding capacity in smokers and nonsmokers. Am Rev Respir Dis 1987; 135(4):783-787.
25. Moreno JJ, Foroozesh M, Church DF, Pryor WA. Release of iron from ferritin by aqueous extracts of cigarette smoke. Chem Res Toxicol 1992;5(1):116-123.
26. Morrison D, Rahman I, Lannan S, MacNee W. Epithelial permeability, inflammation, and oxidant stress in the air spaces of smokers. Am J Respir Crit Care Med 1999;159(2):473-479.